ANIP – ANI Pharmaceuticals Soars to New High After Drug Acquisitions

ANIP stock skyrocketed after ANI Pharmaceuticals announced that it acquired 31 generic drugs from Teva Pharmaceuticals on Friday. More 

5 Big-Name Companies Cutting Jobs

Several big-name companies have recently announced layoffs -- a quick way to cut costs and boost profitability in the absence of substantial organic growth. More 

Teva CEO Resigns 2 Days After Denying Resignation Plans

Despite earlier denials, Teva Pharmaceutical says that Jerry Levin will resign as CEO after disagreeing with the board over its restructuring. More 

Teva Denies CEO Is Stepping Down Amid Board Dispute

Teva Pharmaceuticals have dismissed as "baseless" an Israeli media report that its CEO was stepping down after clashing with its board. More 

Teva Pharmaceuticals to Cut 5,000 Jobs

Teva Pharmaceutical says it will shed 5,000 workers in order to lower costs as it faces increased competition from generic drug makers. More 

5 Stocks Leading the Generic Drug Charge

As pervasive as generic drug usage has already become, experts say there's still lots of room to grow. These companies are leading that charge. More 

How to Profit From Every Biotech Buyout

Amgen's acquisition of Onyx underscores the fact that one simple biotech investment may also be the best one. More